D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 46 Citations 10,064 81 World Ranking 3110 National Ranking 147

Overview

What is he best known for?

The fields of study he is best known for:

  • Immune system
  • Cytokine
  • T cell

His primary areas of study are Natural killer T cell, Immunology, Cell biology, Antigen and CD1D. His study connects Cell culture and Immunology. In his research on the topic of Cell biology, T lymphocyte and Recent Thymic Emigrant is strongly related with CD8.

His Antigen research is multidisciplinary, incorporating elements of T cell, Mucosal associated invariant T cell and T-cell receptor. His T-cell receptor research includes elements of Receptor, Immunity and Spleen. His Major histocompatibility complex study in the realm of Immune system interacts with subjects such as Population.

His most cited work include:

  • CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor (478 citations)
  • Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes. (408 citations)
  • A natural killer T (NKT) cell developmental pathway involving a thymus dependent, NK1.1-CD4+ CD1d-dependent precursor stage (335 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Natural killer T cell, Antigen, T-cell receptor, Cell biology and CD1D. His Natural killer T cell study introduces a deeper knowledge of Immunology. His research in Antigen intersects with topics in Glycolipid and T cell, Immune system, Antigen presentation.

His work deals with themes such as Cell culture, Receptor, Alpha chain, Biochemistry and Crystal structure, which intersect with T-cell receptor. His Cell biology study combines topics in areas such as CD28, Immunological synapse, Mucosal associated invariant T cell and Cell growth. His biological study deals with issues like CD1, which deal with fields such as CD36.

He most often published in these fields:

  • Natural killer T cell (59.83%)
  • Antigen (64.10%)
  • T-cell receptor (62.39%)

What were the highlights of his more recent work (between 2018-2021)?

  • Antigen (64.10%)
  • Cell biology (61.54%)
  • T cell (50.43%)

In recent papers he was focusing on the following fields of study:

Daniel G. Pellicci mostly deals with Antigen, Cell biology, T cell, T-cell receptor and Antigen presentation. His Antigen research is included under the broader classification of Immunology. Daniel G. Pellicci combines subjects such as MAIT Cells, Cell and Mucosal associated invariant T cell with his study of Cell biology.

His T cell research is multidisciplinary, incorporating perspectives in Myeloid, Langerhans cell and CD8. His work in T-cell receptor is not limited to one particular discipline; it also encompasses Receptor. His study focuses on the intersection of CD1D and fields such as CD1 with connections in the field of CD36 and Borrelia burgdorferi.

Between 2018 and 2021, his most popular works were:

  • A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1 (41 citations)
  • A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1 (41 citations)
  • Diverse MR1-restricted T cells in mice and humans. (36 citations)

In his most recent research, the most cited papers focused on:

  • Immune system
  • Cytokine
  • T cell

Daniel G. Pellicci mainly investigates Cell biology, Mucosal associated invariant T cell, Antigen presentation, Minor histocompatibility antigen and Antigen. The various areas that Daniel G. Pellicci examines in his Mucosal associated invariant T cell study include Cell, Cell growth and Signaling lymphocytic activation molecule. His studies in Antigen presentation integrate themes in fields like Natural killer T cell, Major histocompatibility complex and T-cell receptor.

His Minor histocompatibility antigen research incorporates themes from Receptor and MHC class I.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor

Natalie Borg;Kwok Soon Wun;Lars Kjer-Nielsen;Matthew Charles James Wilce.
Nature (2007)

584 Citations

A natural killer T (NKT) cell developmental pathway involving a thymus dependent, NK1.1-CD4+ CD1d-dependent precursor stage

Daniel G. Pellicci;Kirsten J.L. Hammond;Adam P. Uldrich;Alan G. Baxter.
Journal of Experimental Medicine (2002)

429 Citations

IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production.

Jonathan M. Coquet;Konstantinos Kyparissoudis;Daniel G. Pellicci;Gurdyal Besra.
Journal of Immunology (2007)

427 Citations

Differential antitumor immunity mediated by NKT cell subsets in vivo.

Nadine Y. Crowe;Jonathan M. Coquet;Stuart P. Berzins;Konstantinos Kyparissoudis.
Journal of Experimental Medicine (2005)

407 Citations

Recognition of CD1d-restricted antigens by natural killer T cells

Jamie Rossjohn;Daniel G Pellicci;Onisha G Patel;Laurent Gapin.
Nature Reviews Immunology (2012)

380 Citations

Hobit and Blimp1 instruct a universal transcriptional program of tissue residency in lymphocytes.

Laura K. Mackay;Laura K. Mackay;Martina Minnich;Natasja A. M. Kragten;Yang Liao.
Science (2016)

367 Citations

Discordant Regulation of Granzyme H and Granzyme B Expression in Human Lymphocytes

Karin A Sedelies;Thomas J Sayers;Kirsten M Edwards;Weisan Chen.
Journal of Biological Chemistry (2004)

346 Citations

Sequential production of interferon-gamma by NK1.1( ) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide

MJ Smyth;NY Crowe;DG Pellicci;K Kyparissoudis.
Immunobiology (2002)

337 Citations

CD1d-restricted NKT cells: an interstrain comparison.

Kirsten J. L. Hammond;Daniel G. Pellicci;Lynn D. Poulton;Olga V. Naidenko.
Journal of Immunology (2001)

255 Citations

T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate

Laura K. Mackay;Erica Wynne-Jones;David Freestone;Daniel G. Pellicci;Daniel G. Pellicci.
Immunity (2015)

249 Citations

Best Scientists Citing Daniel G. Pellicci

Jamie Rossjohn

Jamie Rossjohn

Monash University

Publications: 210

Dale I. Godfrey

Dale I. Godfrey

University of Melbourne

Publications: 106

Mitchell Kronenberg

Mitchell Kronenberg

La Jolla Institute For Allergy & Immunology

Publications: 84

Gurdyal S. Besra

Gurdyal S. Besra

University of Birmingham

Publications: 71

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 67

James McCluskey

James McCluskey

University of Melbourne

Publications: 65

Vincenzo Cerundolo

Vincenzo Cerundolo

University of Oxford

Publications: 55

Steven A. Porcelli

Steven A. Porcelli

Albert Einstein College of Medicine

Publications: 55

D. Branch Moody

D. Branch Moody

Brigham and Women's Hospital

Publications: 52

Geoffrey R. Hill

Geoffrey R. Hill

Fred Hutchinson Cancer Research Center

Publications: 45

Agnès Lehuen

Agnès Lehuen

Université Paris Cité

Publications: 43

Stephanie Gras

Stephanie Gras

La Trobe University

Publications: 41

Luc Van Kaer

Luc Van Kaer

Vanderbilt University

Publications: 40

Mark A. Exley

Mark A. Exley

Brigham and Women's Hospital

Publications: 39

Laurent Gapin

Laurent Gapin

University of Colorado Anschutz Medical Campus

Publications: 39

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us
Something went wrong. Please try again later.